Whole body imaging in musculoskeletal oncology: when, why, and how.

Skeletal Radiol · Mar 2023 · Review

Vicentini JRT, Bredella MA

Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital and…

Orthopaedic Oncology

SUMMARY — THE REDUCTIONThis review outlines when and how whole-body imaging techniques (MRI, CT, PET-CT) are used in musculoskeletal oncology for assessing tumor burden, metastases, and syndromic surveillance.
Abstract, as published

The use of whole-body imaging has become increasingly popular in oncology due to the possibility of evaluating total tumor burden with a single imaging study. This is particularly helpful in cases of widespread disease where dedicated regional imaging would make the evaluation more expensive, time consuming, and prone to more risks. Different techniques can be used, including whole-body MRI, whole-body CT, and PET-CT. Common indications include surveillance of cancer predisposing syndromes, evaluation of osseous metastases and clonal plasma cell disorders such as multiple myeloma, and evaluation of soft tissue lesions, including peripheral nerve sheath tumors. This review focuses on advanced whole-body imaging techniques and their main uses in musculoskeletal oncology.

Featured in the 2026-09-01 issue.

← The Classic: A System for the Surgical Staging of Musculoskel…What Is the 5-year Survival of Patients With or Without Surge… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.